LEROY Biotech

What LEROY Biotech does

LEROY Biotech is a privately-held French medical device company (SAS, capitalized at 240,000 euros) founded in 2015 and headquartered in Saint-Orens-de-Gameville, France. The company develops, manufactures, and commercializes high-voltage electrochemotherapy generators and specialized electrodes for the treatment of cutaneous and subcutaneous tumors in animals, including sarcoids, squamous cell carcinomas, fibrosarcomas, mast cell tumors, and melanomas in horses, cats, dogs, and small mammals. Its core products are the ELECTROvet S13 and ELECTROvet EZ generators, supported by a proprietary accessory ecosystem of plate, needle (15mm and 25mm), L-shaped, cavity, and nasal electrodes, plus online dosage calculators for Bleomycin and Cisplatin administration.

The company's underlying technology applies controlled high-voltage electrical pulses to permeabilize tumor cell membranes, enabling enhanced uptake of chemotherapy agents with documented efficacy of 97.9% disease-free recovery for equine sarcoids after four years and 87.5% recovery for squamous cell carcinoma in cats. The business model combines one-time hardware device sales with recurring consumable electrode revenue and paid training services for European customers. LEROY Biotech operates a sales-led go-to-market with direct sales to veterinary clinics and universities, complemented by an online store (electrovet.shop), regional channel partners (RXVET Biotech covering North America, Saudi Arabia, and UAE; VETISS covering Poland), and active participation in major veterinary oncology conferences. The customer base spans more than 40 university partners and hundreds of veterinary clinics across 16+ countries, with no external institutional funding, M&A activity, or leadership transitions disclosed.

Name

LEROY Biotech

Legal name

Leroy Biotech S.A.S.

Website

https://leroybiotech.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

LEROY Biotech is a French privately-held manufacturer of high-voltage electrochemotherapy devices (ELECTROvet S13 and EZ) and specialized electrodes for treating cutaneous tumors in horses, cats, dogs, and small mammals, serving veterinary clinics, universities, and research institutions across 16+ countries via direct sales, channel partners, and an online store.

Ownership category

akta.pro rank

Product category

Veterinary Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Surgical & Procedural Instruments (Scalpels, Forceps, Retractors) (HLAMAFAA)

akta.pro secondary industry

Equine Therapeutics (Rx) (HLAMAEAC)

Keywords

• Veterinary electrochemotherapy
• Veterinary oncology devices
• Tumor treatment equipment
• Veterinary medical devices
• Animal cancer therapy

Headquarters

HQ city

Saint-orens-de-gameville

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Electrochemotherapy Device Sales: Sale of ELECTROvet high-voltage generators for electrochemotherapy treatment in veterinary practices
2. Electrode Accessories: Sale of specialized electrodes including plate, needle, L-shaped, cavity, and nasal electrodes at various price points (139-590 euros)
3. Training Services: Paid training offered to European customers during their first electrochemotherapy session

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

LEROY Biotech develops, manufactures, and markets high-voltage electrochemotherapy generators (ELECTROvet EZ and ELECTROvet S13) used by veterinary practitioners to treat cutaneous and subcutaneous tumors in horses, pets, and small mammals. The product portfolio includes proprietary electrode accessories (plate, needle, L-shaped, cavity, and nasal electrodes) and supporting treatment tools such as dosage calculators.

Product overview

LEROY Biotech is the world leader in high-voltage generators for veterinary electrochemotherapy, offering a portfolio of medical devices and accessories. The core product line consists of ELECTROvet S13 and ELECTROvet EZ electrochemotherapy devices, accompanied by a comprehensive range of specialized electrodes (L-shaped, plate, needle 15mm, needle 25mm, cavity, nasal) and control pedals. Online dosage calculators for Bleomycin and Cisplatin support treatment planning. The company serves veterinary clinics, universities, and animal hospitals worldwide, focusing on treating cutaneous tumors including sarcoids, squamous cell carcinomas, fibrosarcomas, and mast cell tumors in horses, cats, dogs, and exotic pets.

Differentiator

Problem solved

Functional benefit

Brands

• ELECTROvet: High-voltage generator device for electrochemotherapy treatment of tumors in veterinary medicine.
• ELECTROvet EZ
• ELECTROcell B15

Products and services

• ELECTROvet EZ Easy-to-use, low-cost electrochemotherapy device for veterinary practices performing tumor treatments in horses, pets, and small mammals. Features intelligent pulse evaluation and ECG synchronization.
• ELECTROvet S13 High-voltage generator for veterinary electrochemotherapy treatment of tumors, used extensively for equine sarcoids and small animal oncology treatments.
• Plate Electrodes Non-invasive electrodes suitable for surface tumors, made of two parallel stainless steel plates (2cm long, 1cm wide, 8mm spacing) that encompass small tumors. Priced at 229 euros.
• L-Shaped Electrodes Designed for cutaneous tumors of any size, particularly large tumors. Ideal for squamous cell carcinomas in small animals, equine sarcoids, and melanomas. Can also treat margins after mast cell tumor or sarcoma surgery. Priced at 219 euros.
• Needle Electrodes (15mm) Delivers homogeneous electrical charge in tissues between two rows of needles for treating solid neoplastic lesions and margins with minimal side effects. Recommended for treating margins under infiltrating tumors like sarcomas. Priced at 239 euros.
• Needle Electrodes (25mm) Longer needle version allowing deeper tissue treatment and treatment of non-resectable tumors.
• Cavity Electrodes Designed for treating oral tumors including base of tongue, areas around teeth, and perianal tumors. Offers precision for smaller areas. Priced at 295 euros.
• Nasal Electrodes Designed for treating tumors located in nasal cavities of dogs. Pack of 2. Priced at 590 euros.
• Simple Pedal Compatible with ELECTROvet EZ V4.0, for charging and triggering pulses. Priced at 130 euros.

Quantifiable outcome

• 99.5% success rate of disease-free recovery after 4 years in horses (Tamzali, 2012)
• +6 more outcomes

Named customers11 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Five partnerships are on record, tiered core and minor.

• RXVET BiotechcoreChannel Partner/ Reseller/ Distributor · 1 October 2018RXVET Biotech is the exclusive channel partner for LEROY Biotech products in North America, Kingdom of Saudi Arabia, and United Arab Emirates. They participate together in veterinary conferences including VCS and AAEP conventions.
• VETISScoreChannel Partner/ Reseller/ Distributor · 15 October 2016VETISS is the distributor for Poland of ultrasounds and ELECTROvet S13 and EZ devices. Organized the first seminar in Poland on treating cutaneous tumors with electrochemotherapy (October 2016, Łódź). Electrochemotherapy now offered in 6 clinics in Krakow, Warsaw, and Tri-City.
• University of LjubljanacoreStrategic or Co-development PartnerAcademic partner with 20 years of electrochemotherapy research experience (Prof. Natasa Tozon). Hosts 2nd Veterinary Workshop on Electroporation-Based Treatments. Joint clinical studies and publication of research on electrochemotherapy in dogs, cats, and horses.
• AnimÔMutminorOthersFrench pet insurance company that covers electrochemotherapy in their dog and cat insurance contracts. One of the few pet insurance providers based entirely in France, referenced with 1500 dog and cat breeders.
• Al Shaqab Equine Veterinary Medical CenterminorStrategic or Co-development PartnerFirst customer for LEROY Biotech in Qatar (Doha). Represents expansion into Middle East equine veterinary market.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Angiodynamics: Listed medical device company with a portfolio that includes NanoKnife, an irreversible electroporation system for soft-tissue ablation. Comparable as a broader incumbent in the electroporation/oncology device space that competes indirectly with ECT generators and signals where the category could consolidate.
• Covetrus: Large global distributor of veterinary products, pharmaceuticals and devices including specialty medical equipment. Comparable as a counterpart in the veterinary device ecosystem, with the ability to either channel-compete or co-distribute ELECTROvet devices alongside LEROY's own distribution.
• SOUND Technologies (now part of Antech): Veterinary imaging and specialty device distributor (ultrasound, digital radiography) commonly sold alongside ECT systems. Comparable as a peer that traverses specialty vet equipment sales channels and supports similar clinical specialties (oncology, surgery).
• VetDC (now part of Elanco): Veterinary oncology therapeutics company historically focused on canine lymphoma drugs, now part of Elanco. Comparable as a veterinary oncology focused entity; overlaps with LEROY only at the customer/use case layer rather than the device layer.

Emerging players

• Pulse Biosciences: Clinical-stage bioelectric medicine company using nanosecond pulsed electric field technology for tumor and tissue applications. Comparable on core electroporation mechanism; differs in focusing on dermatology/oncology in human medicine but represents the underlying tech trajectory LEROY sits within.
• PetVivo Holdings: US veterinary medical device company commercializing injectable implant devices for osteoarthritis and other conditions in companion animals. Comparable as a specialty veterinary device company with a similar go-to-market focus on veterinary clinics, though targeting orthopedics rather than oncology.

Direct peers

• IGEA S.p.A. Italian medical device company that pioneered electrochemotherapy / electroporation devices (Cliniporator). IGEA is the most direct competitor to LEROY Biotech in ECT generators, with overlapping technology and adjacent applications in human oncology that LEROY references on its website.
• Mirai Medical: Developer of pulse/electroporation platforms for electrochemotherapy and irreversible electroporation (IRE). Operates in the same ECT device category as LEROY, focused on tissue ablation and drug uptake in solid tumors, making it the closest product-line analogue.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCcSN3V1fHbayEw6yALtcxLQ
• Facebookfacebook.com/leroybiotech
• LinkedInlinkedin.com/company/leroy-biotech
• Xx.com/leroybiotech1

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LEROY Biotech